Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.05	-69.24	58.66
Graham Fair Price	1501.78	4.21	0.26
PEG	-100.00	< 0.005	-2.07
Price/Book	-47.52	0.09	0.17
Price/Cash Flow	75.28	-1.19	-4.79
Prices/Earnings	-99.43	-1.21	210.92
Price/Sales	37.34	0.49	0.36
Price/FCF	75.28	-1.19	-4.79
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-56.28	0.04	0.09
Operating Margin	3928.38	-0.16	< 0.005
ROA	8720.65	< 0.005	< 0.005
ROE	< 0.005	-0.02	9031.16
ROIC	< 0.005	-0.01	-279.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	0.03	168.92
Dividends QOQ	-0.66	0.67	1.29
EBIT QOQ	1.40	-16.06	1043.31
EPS QOQ	1.02	-151.00	14686.23
FCF QOQ	-1.65	-1.08	34.91
Revenue QOQ	0.46	-0.63	35.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	276.12	694.74	151.61
Days Sales Outstanding (DSO)	77.48	138.39	78.61
Inventory Turnover	0.33	0.13	-60.26
Debt/Capitalization	0.60	0.59	-2.70
Quick Ratio	0.38	0.37	-2.06
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.91	6.55	67.63
Cash	0.78	1.87	139.16
Capex	-0.04	-0.04	-3.03
Free Cash Flow	-0.14	-0.49	-255.80
Revenue	1.84	1.18	-35.95
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.20	1.32	10.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	52.04	-64.30	23.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating